The liver metabolizes many medicines and as a result is vulnerable to damage from drugs or their byproducts.
Liver cells may aid drug-safety studies
Key is getting them to act as the organ would
The liver metabolizes many medicines and as a result is vulnerable to damage from drugs or their byproducts.
Potential new drugs sometimes fail because they damage the liver, but the problem may not turn up until companies have embarked on expensive clinical trials - or until the medicine is on the market. (Full article: 806 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
